BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37560302)

  • 21. The longest reported survival of a child with McCune-Albright syndrome and a severe early presenting phenotype consisting of neonatal cushing syndrome, cardiac and liver diseases.
    Alhalabi R; Elsayed Y; Belsha D; Muad H; Zidan H; Alhubaishi LY; Ramaiah S; Ba'ath ME
    J Surg Case Rep; 2023 Jul; 2023(7):rjad409. PubMed ID: 37489160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. McCune-Albright syndrome: clinical picture and natural history in children and adolescents.
    Völkl TM; Dörr HG
    J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():551-9. PubMed ID: 16789617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cushing's syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome.
    Kirk JM; Brain CE; Carson DJ; Hyde JC; Grant DB
    J Pediatr; 1999 Jun; 134(6):789-92. PubMed ID: 10356155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and endocrine characteristics and genetic analysis of Korean children with McCune-Albright syndrome: a retrospective cohort study.
    Cho EK; Kim J; Yang A; Ki CS; Lee JE; Cho SY; Jin DK
    Orphanet J Rare Dis; 2016 Aug; 11(1):113. PubMed ID: 27506760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and management of precocious puberty in atypical presentations of McCune-Albright syndrome: a case series review.
    Bercaw-Pratt JL; Moorjani TP; Santos XM; Karaviti L; Dietrich JE
    J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):e9-e13. PubMed ID: 22051789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metyrapone as treatment in the neonatal McCune-Albright syndrome.
    de Mingo C; Brugada M; León S; Moreno F; Vila N; Palanques-Pastor T; Poveda JL; Orti C; García-Robles A
    J Pediatr Endocrinol Metab; 2020 Jul; ():. PubMed ID: 32697759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment with metyrapone of Cushing's syndrome revealing McCune-Albright syndrome].
    Halioui-Louhaichi S; Azzabi O; Nefzi L; Ben Hariz M; Ben Mrad N; Ben Ammar B; Maherzi A
    Arch Pediatr; 2005 Jul; 12(7):1120-3. PubMed ID: 15964528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome.
    Leet AI; Chebli C; Kushner H; Chen CC; Kelly MH; Brillante BA; Robey PG; Bianco P; Wientroub S; Collins MT
    J Bone Miner Res; 2004 Apr; 19(4):571-7. PubMed ID: 15005844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic Lesions Associated With McCune Albright Syndrome.
    Johansen L; Haller W; Thyagarajan M; Kelly D; McKiernan P
    J Pediatr Gastroenterol Nutr; 2019 Apr; 68(4):e54-e57. PubMed ID: 30628989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Research progress on the pathogenic mechanisms, diagnosis and treatment of McCune-Albright syndrome].
    Mu D; Liu HQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Feb; 58(2):183-190. PubMed ID: 38387948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. McCune-Albright syndrome, a rare form of precocious puberty: Diagnosis, treatment, and follow-up.
    Gryngarten M; Comar H; Arcari A; Boulgourdjian E; Escobar ME; Domené H
    Arch Argent Pediatr; 2021 Oct; 119(5):e420-e427. PubMed ID: 34569743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. McCune-Albright syndrome and type 1 diabetes mellitus: a novel presentation.
    Chatty P; Khattab A; Marshall I
    Ann N Y Acad Sci; 2020 Mar; 1463(1):5-8. PubMed ID: 32037600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACTH-independent Cushing's syndrome due to ectopic endocrinologically functional adrenal tissue caused by a
    Takedani K; Yamamoto M; Tanaka S; Ishihara S; Taketani T; Kanasaki K
    Front Endocrinol (Lausanne); 2022; 13():934748. PubMed ID: 35966069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of aberrant adrenocorticotropic hormone precursors in two cases of McCune-Albright syndrome.
    Takayasu S; Makita K; Kageyama K; Okawa Y; Oki Y; Yamagata S; Asari Y; Terui K; Daimon M
    Endocr J; 2020 Mar; 67(3):353-359. PubMed ID: 31801917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [McCune-Albright syndrome: a case report and literature review].
    Chabouni H; Jemaa MB; Ghorbel M; Trigui M; Zribi W; Zribi M; Ayadi K; Aoui M; Keskes H
    Pan Afr Med J; 2023; 46():33. PubMed ID: 38145201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. McCune-Albright Syndrome in Infant with Growth Hormone Excess.
    Brzica K; Simunovic M; Ivancic M; Tudor D; Skrabic I; Skrabic V
    Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 36011254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple neonatal endocrinopathies in McCune-Albright syndrome.
    Bareille P; Azcona C; Stanhope R
    J Paediatr Child Health; 1999 Jun; 35(3):315-8. PubMed ID: 10404460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Café-au-lait spots" caused by vitiligo in McCune-Albright syndrome.
    Whyte MP; Podgornik MN; Zerega J; Reinus WR
    J Bone Miner Res; 2000 Dec; 15(12):2521-3. PubMed ID: 11127218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sudden onset vision loss in an 8-year-old female with McCune-Albright syndrome.
    Kim D; Wysong A; Lai J; Alcorn DM; Benjamin LT
    Pediatr Dermatol; 2014; 31(1):80-2. PubMed ID: 23013381
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.